Behandlung/ treatment
» weitere eventuell wirksame Nahrungsergänzungsmittel, Vitamine/ other supplements
Letzte Änderung: 21.01.2021 um 08:43 Uhr
Auch bei frei verkäuflichen Arzneimitteln/ Vitaminen/ Nahrungsergänzungsmitteln sollte vor einer Einnahme immer unbedingt Rücksprache mit seinem Arzt genommen werden. Es können auch schädliche unerwünschte Wirkungen auftreten.
Weiterführende Links zum Artikel
Efficacy of honey and Nigella sativa against COVID-19: HNS-COVID-PK Trial
(Hinzugefügt: 21.01.2021 um 08:42 Uhr)
Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets
(Hinzugefügt: 20.01.2021 um 08:10 Uhr)
Possible Prophylactic Approach for SARS-CoV-2 Infection by Combination of Melatonin, Vitamin C and Zinc in Animals
(Hinzugefügt: 23.12.2020 um 08:47 Uhr)
Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?
(Hinzugefügt: 15.12.2020 um 09:41 Uhr)
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches Author links open overlay panel
(Hinzugefügt: 13.12.2020 um 10:48 Uhr)
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro
(Hinzugefügt: 11.12.2020 um 08:04 Uhr)
Significant inactivation of SARS-CoV-2 by a green tea catechin, a catechin-derivative and galloylated theaflavins in vitro
(Hinzugefügt: 09.12.2020 um 18:45 Uhr)
Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2
(Hinzugefügt: 03.12.2020 um 12:23 Uhr)
A pomegranate peel extract as inhibitor of SARS-CoV-2 Spike binding to human ACE2 (in vitro): a promising source of novel antiviral drugs
(Hinzugefügt: 02.12.2020 um 22:10 Uhr)
Dietary supplements during the COVID-19 pandemic: insights from 1.4M users of the COVID Symptom Study app - a longitudinal app-based community survey
(Hinzugefügt: 01.12.2020 um 08:00 Uhr)
Deciphering underlying mechanism of Sars-CoV-2 infection in humans and revealing the therapeutic potential of bioactive constituents from Nigella sativa to combat COVID19: in-silico study
(Hinzugefügt: 29.11.2020 um 13:21 Uhr)
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
(Hinzugefügt: 28.11.2020 um 09:38 Uhr)
Structural and physico-chemical evaluation of melatonin and its solution-state excited properties, with emphasis on its binding with novel coronavirus proteins
(Hinzugefügt: 24.11.2020 um 20:46 Uhr)
Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study
(Hinzugefügt: 24.11.2020 um 09:14 Uhr)
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients (NICOVID-REA)
(Hinzugefügt: 24.11.2020 um 09:08 Uhr)